C

Agilent Technologies, Inc. A

$155.74 -$0.60-0.38% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Agilent Technologies, Inc. is an American analytical instrumentation and life sciences company that develops and manufactures instruments, software, services, consumables, and laboratory workflows used in diagnostics, pharmaceutical research, chemical analysis, environmental testing, food safety, and academic research. The company operates primarily in the life sciences and applied markets industries, serving customers including pharmaceutical and biotechnology companies, clinical laboratories, academic institutions, government agencies, environmental testing organizations, and industrial manufacturers. Agilent’s principal revenue drivers include analytical instruments, laboratory consumables, cross-lab services, diagnostics products, and recurring service contracts. The company is widely recognized for its positions in chromatography, mass spectrometry, spectroscopy, pathology diagnostics, and laboratory informatics.

Agilent was formed in 1999 as a spin-off from Hewlett-Packard’s measurement and analytical businesses. Over time, the company shifted from a broader electronic measurement portfolio toward life sciences, diagnostics, and applied chemical markets through restructuring and acquisitions. Major strategic moves included the separation of its electronic measurement business into Keysight Technologies in 2014 and acquisitions such as Dako, BioTek Instruments, and Resolution Bioscience, which expanded its diagnostics and cell analysis capabilities. Agilent’s competitive positioning is supported by a large installed instrument base, recurring consumables and service revenue, global laboratory relationships, and integrated workflow offerings across research and clinical applications.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Tuesday, September 1, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Dec 21 and 25 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
800 227 9770
Address
5301 Stevens Creek Boulevard
Santa Clara, CA 95051
Country
Year Founded

Headlines

9/17/2026 - Nasdaq News: Stocks